- Home
- GURE vs MYNZ Comparison
GURE vs MYNZ Comparison
Compare GURE & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GURE
- MYNZ
- Stock Information
- Founded
- GURE 2006
- MYNZ 2021
- Country
- GURE China
- MYNZ Germany
- Employees
- GURE N/A
- MYNZ N/A
- Industry
- GURE Major Chemicals
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- GURE Industrials
- MYNZ Health Care
- Exchange
- GURE Nasdaq
- MYNZ Nasdaq
- Market Cap
- GURE 8.5M
- MYNZ 8.0M
- IPO Year
- GURE 1992
- MYNZ 2021
- Fundamental
- Price
- GURE $0.62
- MYNZ $2.08
- Analyst Decision
- GURE
- MYNZ Buy
- Analyst Count
- GURE 0
- MYNZ 2
- Target Price
- GURE N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- GURE 43.7K
- MYNZ 92.3K
- Earning Date
- GURE 05-13-2025
- MYNZ 06-17-2025
- Dividend Yield
- GURE N/A
- MYNZ N/A
- EPS Growth
- GURE N/A
- MYNZ N/A
- EPS
- GURE N/A
- MYNZ N/A
- Revenue
- GURE $7,958,395.00
- MYNZ $893,991.00
- Revenue This Year
- GURE N/A
- MYNZ $26.06
- Revenue Next Year
- GURE N/A
- MYNZ $4.97
- P/E Ratio
- GURE N/A
- MYNZ N/A
- Revenue Growth
- GURE N/A
- MYNZ N/A
- 52 Week Low
- GURE $0.50
- MYNZ $1.92
- 52 Week High
- GURE $1.75
- MYNZ $34.00
- Technical
- Relative Strength Index (RSI)
- GURE 48.34
- MYNZ 38.07
- Support Level
- GURE $0.56
- MYNZ $1.93
- Resistance Level
- GURE $0.68
- MYNZ $2.10
- Average True Range (ATR)
- GURE 0.04
- MYNZ 0.16
- MACD
- GURE 0.00
- MYNZ 0.04
- Stochastic Oscillator
- GURE 55.38
- MYNZ 30.39
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.